RxDoctor Payments Data

Sarah Haden Vance, NP

Psychiatric/Mental Health · Hoover, ALNPI 1609474725

Payments from drug & device makers

$3,884in general payments, 2019–2025

Across 180 payments — averaging $21.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$725
  • Otsuka America Pharmaceutical, Inc.$658
  • Axsome Therapeutics, Inc.$437
  • Johnson & Johnson$329
  • Teva Pharmaceuticals USA, Inc.$304
  • Vanda Pharmaceuticals Inc.$286
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$3,884100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,884 in reported general payments places this provider in the 75th percentile of 378 psychiatric/mental health providers in Alabama.

See all psychiatric/mental health providers in Alabama

Medicare billing

Part B allowed, 2024
$5,409
Medicare patients
13
Services billed
58

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl19$27,701
Bupropion XlBupropion Hcl14$1,081
Divalproex Sodium ErDivalproex Sodium16$947
Ziprasidone Hcl12$703
Quetiapine Fumarate52$465
Divalproex Sodium17$446
Sertraline Hcl41$398
Trazodone Hcl87$362
Desvenlafaxine Succinate ErDesvenlafaxine Succinate12$286
Olanzapine21$277
Venlafaxine Hcl14$255
Duloxetine Hcl14$224
Mirtazapine16$209
Lithium Carbonate11$206
Fluoxetine Hcl28$177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$278$27,70119 claims
Almatica Pharma LLCSertraline Hcl$22$39841 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 378 psychiatric/mental health providers in Alabama.

Other psychiatric/mental health in Hoover

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →